TFB2M and non-small cell lung carcinoma: Consistent with the HKP1 model, GO analysis (Log2FC >0.5, FDR <10%, p value < 0.05) highlighted alterations in immune-mediated processes in the IRE1αKO upregulated signature human NSCLC cohort (Fig. 5c).